Jump to content

Webcast - EU Clinical Trial Regulation

RQA Member: USD ($) 26.00
Non-Member: USD ($) 51.00

Your Price: USD ($) 51.00

Please note payment is required before access is given. However, if you need earlier access to the webcast please contact webcasts@therqa.com.

Webcast Information

The new EU Clinical Trials Regulation has been made final! Some have heralded it as the biggest change to Clinical Trials since the EU Clinical Trials Directive (2001/20/EC). The EU is dramatically changing the law regarding clinical trials. The RQA GCP Committee offers a 'heads-up' on some of the GCP aspects of the new Clinical Trials Regulation, from a clinical auditors point of view.

  • Looking for the possible future Inspection/Audit finding risks!
  • How protocols might have to change to avoid this
  • Where the dangers with Serious Breaches & USMs may be
  • Changes to the definition of GCP
  • Reporting third country inspections
  • Consent changes
  • Risk adaption and more.

The GMP and GPvP aspects are not covered.

This on-demand webcast is approximately 60 minutes in duration.

View a taster below



Recommended Products


Comparison of Pharmacovigilance Regulations in Europe and Japan
Good Clinical Practice Regulatory Authority Inspections
Management of the Training and Competency of Personnel in GxP and Research Environments


Virtual Event Platform